DVYSR — Devyser Diagnostics AB Share News
0.000.00%
- SEK844.49m
- SEK809.29m
- SEK250.50m
Brief: Devyser Signs Deal With Italian Laboratory
Brief: Devyser Reports Q2 EBITA Of SEK 0.5 Million
Sweden's Devyser Diagnostics Q2 sales fall on distributor inventory adjustment
Brief: Devyser Q2 Sales At SEK 60.2 Mln, Weaker Than Expected
Sweden's Devyser Q2 prelim sales weaken on distributor inventory build-up
Brief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue
Brief: Devyser Diagnostics Board Not Proposing Dividend For 2025
Sweden's Devyser Q4 sales rise 12.1% yr/yr
Brief: Devyser Buys Cybergene AB
Brief: Devyser Enters Strategic Supply Agreement With Illumina
Brief: Devyser Wins Norwegian Tender For Devyser CFTR At Oslo University Hospital
Brief: Devyser Wins Four-Year Tender In France
Brief: CMS Sets Price For Devyser's Prenataldetect RHD Test At $192
Brief: Devyser Q3 Sales SEK 56.4 Million
Brief: Devyser Diagnostics CEO Buys SEK 508,682 Worth Of Co's Shares